
    
      To Evaluate the efficacy and longevity of a Human-derived, non-cadaveric, acellular dermal
      implant (BellaDerm) as a posterior spacer graft in the correction of lower eyelid retraction,
      taking into consideration issues associated with the use of acelular dermis such as
      contraction and potential regression of repairs.
    
  